94 related articles for article (PubMed ID: 20697074)
1. Technology evolution: is it survival of the fittest?
Zietman A; Goitein M; Tepper JE
J Clin Oncol; 2010 Sep; 28(27):4275-9. PubMed ID: 20697074
[TBL] [Abstract][Full Text] [Related]
2. Procedures and methods of benefit assessments for medicines in Germany.
Bekkering GE; Kleijnen J
Eur J Health Econ; 2008 Nov; 9 Suppl 1():5-29. PubMed ID: 18987905
[TBL] [Abstract][Full Text] [Related]
3. Beware the Medical-Industrial Complex.
Stevens CW; Glatstein E
Oncologist; 1996; 1(4):IV-V. PubMed ID: 10388005
[TBL] [Abstract][Full Text] [Related]
4. Shattuck Lecture--Hidden barriers to improvement in the quality of care.
McNeil BJ
N Engl J Med; 2001 Nov; 345(22):1612-20. PubMed ID: 11757509
[No Abstract] [Full Text] [Related]
5. Advanced topics in evidence-based urologic oncology: economic analysis.
Vogel B; Gilbert SM; Boylston Herndon J; Dahm P
Urol Oncol; 2011; 29(4):454-61. PubMed ID: 21726796
[TBL] [Abstract][Full Text] [Related]
6. American Society of Clinical Oncology guidance statement: the cost of cancer care.
Meropol NJ; Schrag D; Smith TJ; Mulvey TM; Langdon RM; Blum D; Ubel PA; Schnipper LE;
J Clin Oncol; 2009 Aug; 27(23):3868-74. PubMed ID: 19581533
[TBL] [Abstract][Full Text] [Related]
7. Diffusion of new technologies: rational and irrational.
Perry S
J Health Care Technol; 1984; 1(2):73-88. PubMed ID: 10271139
[TBL] [Abstract][Full Text] [Related]
8. Ending the technology paradox: healthcare management technologies for clinical decision making.
Karys A
J Healthc Inf Manag; 1998; 12(3):25-32. PubMed ID: 10338784
[TBL] [Abstract][Full Text] [Related]
9. Proton beam therapy: too expensive to become true?
Lievens Y; Van den Bogaert W
Radiother Oncol; 2005 May; 75(2):131-3. PubMed ID: 15890422
[No Abstract] [Full Text] [Related]
10. Regarding: Rosenthal DI, Glatstein E. "We've Got a Treatment, but What's the Disease?" The Oncologist 1996;1.
Lunsford LD; Flickinger JC; Larson D
Oncologist; 1997; 2(1):59-61. PubMed ID: 10388030
[TBL] [Abstract][Full Text] [Related]
11. A clinical approach to technology assessment: how do we and how should we choose the right treatment?
Zietman A; Ibbott G
Semin Radiat Oncol; 2012 Jan; 22(1):11-7. PubMed ID: 22177874
[TBL] [Abstract][Full Text] [Related]
12. Evidence-based medicine, systematic reviews, and guidelines in interventional pain management, part I: introduction and general considerations.
Manchikanti L
Pain Physician; 2008; 11(2):161-86. PubMed ID: 18354710
[TBL] [Abstract][Full Text] [Related]
13. [Procedures and methods of benefit assessments for medicines in Germany].
Bekkering GE; Kleijnen J
Dtsch Med Wochenschr; 2008 Dec; 133 Suppl 7():S225-46. PubMed ID: 19034813
[TBL] [Abstract][Full Text] [Related]
14. Introduction of emerging medical devices on the market: a new procedure in Belgium.
Vinck I; Neyt M; Thiry N; Louagie M; Ramaekers D
Int J Technol Assess Health Care; 2007; 23(4):449-54. PubMed ID: 17937833
[TBL] [Abstract][Full Text] [Related]
15. Economic evaluation of proton radiation therapy in the treatment of breast cancer.
Lundkvist J; Ekman M; Ericsson SR; Isacsson U; Jönsson B; Glimelius B
Radiother Oncol; 2005 May; 75(2):179-85. PubMed ID: 15885828
[TBL] [Abstract][Full Text] [Related]
16. Cost analysis of radiotherapy, carbon ion therapy, proton therapy and BNCT in Japan.
Nakagawa Y; Yoshihara H; Kageji T; Matsuoka R; Nakagawa Y
Appl Radiat Isot; 2009 Jul; 67(7-8 Suppl):S80-3. PubMed ID: 19394238
[TBL] [Abstract][Full Text] [Related]
17. [Development of antituberculous drugs: current status and future prospects].
Tomioka H; Namba K
Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
[TBL] [Abstract][Full Text] [Related]
18. Should positive phase III clinical trial data be required before proton beam therapy is more widely adopted? No.
Suit H; Kooy H; Trofimov A; Farr J; Munzenrider J; DeLaney T; Loeffler J; Clasie B; Safai S; Paganetti H
Radiother Oncol; 2008 Feb; 86(2):148-53. PubMed ID: 18237800
[TBL] [Abstract][Full Text] [Related]
19. Year-end perspectives: the introduction of new technologies.
Williams D
Med Device Technol; 2003 Dec; 14(10):10-2. PubMed ID: 14981885
[TBL] [Abstract][Full Text] [Related]
20. The changing environment for technological innovation in health care.
Goodman CS; Gelijns AC
Baxter Health Policy Rev; 1996; 2():267-315. PubMed ID: 11066263
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
